Study Title
Phase I/II Trial of Deflexifol for Refractory/Recurrent Paediatric Ependymoma
Protocol ID
DEFLEXIFOL (DART)
Disease (Sub Disease)
Ependymoma
Diagnosis Stage
Relapsed/refractory
Location
NSW, QLD, VIC, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Links
Trial Status
Open
Sites
Sydney Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
John Hunter Children's Hospital
Monash Children's Hospital
The Royal Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
John Hunter Children's Hospital
Monash Children's Hospital
The Royal Children's Hospital
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
12 Months to 21 Years
ANZCTR
ACTRN12623000104651
| Study Title | Phase I/II Trial of Deflexifol for Refractory/Recurrent Paediatric Ependymoma |
|---|---|
| Protocol ID | DEFLEXIFOL (DART) |
| Disease (Sub Disease) | Ependymoma |
| Diagnosis Stage | Relapsed/refractory |
| Location | NSW / QLD / VIC / WA |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
| Links | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384863&isReview=true |
| Trial Status | Open |
| Trial Open Date | 28/08/2023 |
| Sites | Sydney Children's Hospital/ Perth Children's Hospital / Queensland Children's Hospital / John Hunter Children's Hospital/ Monash Children's Hospital/ The Royal Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 1/2 |
| Age Eligibility | 12 Months to 21 Years |
| ANZCTR | ACTRN12623000104651 |